Australia antigen and primary biliary cirrhosis

Area of Science:

• Hepatology
• Immunology
• Virology

Background:

• Primary biliary cirrhosis (PBC) is a chronic liver disease of unknown etiology.
• The role of viral infections, particularly hepatitis B virus (HBV), in PBC pathogenesis is debated.

Purpose of the Study:

• To investigate the prevalence of Australia antigen (Au) and anti-Au antibodies in patients with primary biliary cirrhosis (PBC).
• To explore the potential association between Au antigen and PBC using sensitive detection methods.

Main Methods:

• Sera from 64 PBC patients and matched controls were tested for Australia antigen (Au) using immunodiffusion, immunoelectrophoresis, and radioimmunoprecipitation.
• Antibodies to Au (anti-Au) were also assessed.
• Lymphocyte transformation assays were performed on a subset of patients stimulated with Au-rich serum.

Main Results:

• Standard serological tests (immunodiffusion, immunoelectrophoresis) were negative for Au antigen in all PBC sera.
• Radioimmunoprecipitation detected Au antigen in 15.6% of PBC patients, significantly higher than the 3.1% in controls (p = 0.015).
• Anti-Au antibodies were found in 9.4% of PBC patients and 7.8% of controls. Lymphocytes from one patient transformed upon stimulation with Au-rich serum.

Conclusions:

• A higher prevalence of Australia antigen (Au) is detected in primary biliary cirrhosis (PBC) patients using sensitive radioimmunoprecipitation, suggesting a potential association.
• The findings indicate that Au antigen may play a role in the pathogenesis or be a marker of PBC.
• Further research is needed to elucidate the exact relationship between Au antigen and PBC.